Increased H1 profits drive Sanitas' expansion plans in Russia
This article was originally published in Scrip
Executive Summary
Sanitas, Lithuania's largest pharmaceutical manufacturer, wants to expand in Russia on the back of increased six-month revenues and profits; it hopes that the country's share in its total sales will rise from the current 14% to 20% by the end of this year.